Domestic Sales Expected to Surpass 300 Billion Won This Year
Market Interest Grows Amid Aging Population and Rise in Chronic Disease Patients

"My grandmother was no longer able to eat as much as she used to. I was worried she might not be getting enough nutrition, so I looked for a product that would help her supplement her nutrition more easily and ordered it for her."


The so-called "medifood" market, which targets patients such as those with cancer, diabetes, or kidney disease, is steadily scaling up. As the population ages and the number of people with chronic diseases increases rapidly, the demand for "nutrient-rich" foods that are tasty and can serve as meal replacements has grown. With more diverse sales channels such as online platforms, even health-conscious individuals can easily access these products, prompting food and meal service companies to continuously launch new offerings.

"Tasty and Nutrient-Rich"... Medifood Market Soaring View original image

According to the relevant industry on July 1, the domestic sales of food for special medical purposes are expected to surpass 300 billion won this year. The sales of food for special medical purposes reached 296 billion won last year, a 25% increase compared to 2022. Although it only accounts for 0.4% of the overall food market, the market for food for special medical purposes is considered a new sector in Korea, where overall sales expansion potential is limited.


Food for special medical purposes refers to products formulated and manufactured to help patients with restricted normal nutrition intake, digestion, absorption, or metabolism due to disease or specific health conditions. These meals are primarily for diabetic patients, those with kidney disease, cancer patients, and others who require specialized diets. Recently, purchases have also increased for family members, such as parents or grandparents who have difficulty eating, or for consumers who are mindful of nutritional content.


Food for special medical purposes is classified into three categories: ▲Standard nutritional formula meals that replace regular meals for those needing to maintain or recover strength, ▲Customized nutritional formula meals for patients who require different nutritional support because of illness or surgery, and ▲Meal-type management foods designed to help people with chronic diseases manage their diet conveniently. Standard or customized nutritional formula and meal-type foods are mainly sold in liquid or powder form, while meal-type products are offered in familiar formats like lunch boxes or meal kits.

"Tasty and Nutrient-Rich"... Medifood Market Soaring View original image

The largest segment within food for special medical purposes, general balanced nutritional formula for patients, surpassed 200 billion won in sales for the first time last year—a 29% increase compared to three years ago. "New Care" from Daesang Wellife is a representative example. Launched in 1995 for elderly people and patients, New Care currently operates 77 SKUs in the special medical purposes category. In addition to continued purchases by patients who encountered these products in hospitals after their discharge, there has recently been an increase in online orders and deliveries to parents or grandparents who have difficulty eating due to the aging population.


Based on this, Daesang Wellife's sales of food for special medical purposes surpassed 220 billion won last year. The company's domestic sales in this market reached the 200 billion won range for the first time in 2023 and have continued to grow. A representative from Daesang Wellife explained, "We operate both offline channels such as hospitals and pharmacies, as well as our own mall and major online channels. The online channel accounts for a higher proportion of sales than offline, and B2C sales are also higher than B2B sales to hospitals and similar institutions."


The market for meal-type management products, which began to launch and be sold after the Ministry of Food and Drug Safety revised its notification in 2020, is also growing rapidly. Compared to 2022, when related statistics were first compiled, the domestic sales of meal-type management products among food for special medical purposes jumped by 137% to 5.4 billion won last year.


One of the leading meal-type management product brands, "Greeting" by Hyundai Green Food, saw its revenue from disease-specific meal plans grow at an average annual rate of 34% over the three years from 2022 to last year. The number of SKUs also more than doubled, from 153 three years ago to 331 currently. A Hyundai Green Food representative said, "Sales of disease-specific meal plans have continued to grow by double digits this year as well."


By disease type, sales of products for kidney disease patients have risen sharply. For meal-type foods for kidney disease, sales were less than 50 million won in 2022 but soared to about 2.5 billion won last year, recording a growth rate of over 5,000%. Hyundai Green Food's sales of kidney-specific meal plans also grew by more than 40% year-on-year, showing a higher growth rate than other products. Sales of nutritional formula products for kidney disease also increased by 59% during the same period, reaching 6.26 billion won last year. Sales of foods for various conditions, including cancer and diabetes, are also on the rise.


An industry insider commented, "Because these products are typically sought after by people who need to control their diet, once they start buying, the likelihood that they will continue to purchase is high. Although the market size is still relatively small, it is expected to grow as more general consumers show interest."



Meanwhile, the medifood market is expanding not only in Korea but also worldwide, driven by population aging and an increase in chronic disease patients. According to the Ministry of Food and Drug Safety, the global medifood market is projected to grow at an average annual rate of 5.1% from USD 23.59 billion (about 3.66 trillion won) in 2023 to USD 38.9 billion in 2033. Currently, the export volume of Korean medifood products was recorded at USD 4.55 million last year.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing